A review of discrete event simulation in National Coordinating Centre for Health Technology Assessment-funded work and a case study exploring the cost-effectiveness of testing for thrombophilia in patients presenting with an initial idiopathic venous thromboembolism

2010 ◽  
Vol 4 (1) ◽  
pp. 14-23 ◽  
Author(s):  
M D Stevenson ◽  
E L Simpson ◽  
A C Rawdin ◽  
D E Papaioannou
Keyword(s):  
Venous Thromboembolism ◽  
Cost Effectiveness ◽  
Health Technology Assessment ◽  
Discrete Event Simulation ◽  
Technology Assessment ◽  
Discrete Event ◽  
Health Technology ◽  
Event Simulation ◽  
The Cost

Discrete Event Simulation for Health Technology Assessment

2015 ◽  
Author(s):  
J. Jaime Caro ◽  
Jörgen Möller ◽  
Jonathan Karnon ◽  
James Stahl ◽  
Jack Ishak
Keyword(s):  
Health Technology Assessment ◽  
Discrete Event Simulation ◽  
Technology Assessment ◽  
Discrete Event ◽  
Health Technology ◽  
Event Simulation

scholarly journals Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment

2017 ◽  
Vol 35 (10) ◽  
pp. 989-1006 ◽  
Author(s):  
Syed Salleh ◽  
Praveen Thokala ◽  
Alan Brennan ◽  
Ruby Hughes ◽  
Simon Dixon
Keyword(s):  
Health Technology Assessment ◽  
Discrete Event Simulation ◽  
Technology Assessment ◽  
Discrete Event ◽  
Health Technology ◽  
Event Simulation ◽  
Simulation Based ◽  
Resource Modelling

OP141 Health Technology Assessment In India: Current Scenario And Way Forward

2020 ◽  
Vol 36 (S1) ◽  
pp. 1-2
Author(s):  
Komal Shah ◽  
Somen Saha ◽  
Priya Kotwani ◽  
Malkeet Singh ◽  
Kirti Tyagi
Keyword(s):  
Public Health ◽  
Cost Effectiveness ◽  
Health Technology Assessment ◽  
Technology Assessment ◽  
Health Technology ◽  
Cochrane Library ◽  
Economic Evaluations ◽  
Healthcare Budget ◽  
Life Years ◽  
The Cost

IntroductionIndia has introduced health technology assessment (HTA) as a tool for improving the allocation of health resources. The core mandate of HTA in India (HTAIn) is to undertake critical appraisal of available technologies, identify cost-effective interventions, and help the government pursue evidence-informed decisions regarding public health expenditures. We conducted a systematic review to assess economic evaluation studies published in the last four years from India.MethodsEconomic evaluations published from September 2015 to September 2019 were identified by searching various databases, including PubMed, Scopus, Embase, The Cochrane Library, and CINAHL according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. Cost-effectiveness studies and HTAs reported or conducted in India were included. Two independent reviewers performed the final selection of studies by assessing the full-text articles and conducted the data extraction. Differences of opinions were resolved through discussion and mutual consensus.ResultsAfter screening 2,837 articles, seventy met the inclusion criteria and were selected. The articles predominantly used secondary data (70%) to evaluate the cost effectiveness of an innovation. Among the technologies assessed, fifty-seven percent were curative in nature and most commonly addressed infectious diseases (27%), closely followed by non-communicable diseases, and maternal and child health. Principally, the cost effectiveness of a technology was expressed in terms of disability-adjusted or quality-adjusted life-years. Only two studies reported negative findings.ConclusionsHTA can play a pivotal role in equipping policy makers and public health payers to make appropriate decisions for healthcare budget allocations when mapped with the true disease burden of the population. It is important to highlight negative results and to create a national repository of HTA studies to facilitate faster adoption of best practices in India.

Sign in / Sign up

Export Citation Format

Share Document